All Articles
Great Expectations for Personalized Medicine Outside Oncology

Great Expectations for Personalized Medicine Outside Oncology

21 June, 2016

We are all familiar with personalized medicine in oncology but future developments involving new technologies are likely to flourish in other disease areas. Peter Keeling and Steve Vitale of Diaceutics look at challenges and opportunities in the non-oncology space.

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.